LEP General

LEP;

Aims and objectives (20); Computers (98, 119-120, 122, 126, 128-129, 132-133, 136-137, 140); Concerns (59-60, 63) Control Project (74)

Data (103): Processing Unit in Blantyre (107-108, 113-114, 122, 126);

Finance: Appeal to Trusts (77-78), Estimates (122, 127, 130-131), Expenditure (50.

Future of LEP (8-9, 28-30, 34, 35-46, 48-49, 53-54, 57-61, 64): Assessment 8-10, 13);

Histopathology (66-67, 99, 104-106, 116, 135, 138, 143); ILEP (90-91, 111)' London School of Hygiene (97-98, 100-102); Management (4, 15-16, 18-19, 21, 31); Medical Advisory Board (6, 30, 34, 37-46, 49, 53-54, 59-60, 63); Primary Health Care (115, 121); Reagents (52, 94-95);

Reports: Dr. Noordeen - WHO (26-27); Research Collaboration (47);

Second survey (11, 24, 73, 85-87, 89, 113): Dr. Morrow (35, 51, 55-56, 65, 68-72, 75-76, 79), Report (81-82, 87-88, 94, 124);

Staff: Assistant for Jörg (23); Computer Assistant (32); Programmer/analyst (32); Secretary/Admin assistant London (32-33, 109a); Ian Sliney (23, 141-142); Statistician (94-95, 117);

Sub-Committee (109):

Vaccine Trial (5, 7, 14, 22, 33, 73-74, 84, 113, 123, 139): IMMLEP Meeting (80, 94, 96, 109-110, 112-114, 118); Insurance (125)

Visits: Dr. Jesudasan (83, 92-93, 134); Dr. Noordeen - WHO (25-27);